- Abbott (NYSE:ABT) Q3 results:
- Revenues: $8,853M (+9.6%); Medical Devices: $3,170M (+3.4%); Diagnostics: $2,640M (+38.2%); Nutrition: $1,924M (+2.6%); Established Pharmaceuticals: $1,099M (-9.3%).
- Net income: $1,232M (+28.5%); EPS: $0.69 (+30.2%).
- 2020 guidance: EPS: at least $2.35; non-GAAP EPS: at least $3.55.
- https://seekingalpha.com/news/3624134-abbott-q3-top-line-up-10-diagnostics-up-38-on-covidminus-19-demand
Wednesday, October 21, 2020
Abbott Q3 top line up 10%, diagnostics up 38% on COVID-19 demand
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.